by Adrià Rivero - Inversión en Bolsa | 12/04/2025 09:00 AM | AKSO.OL
🏹 A 'hunter' investor turned a potential 40% loss in Aker Solutions into a 24% gain by strategically buying more shares as the price fell.
💰 Averaging down requires strong conviction in the original investment thesis remaining intact despite the price decline.
⚠️ This strategy involves concentration risk and should only be applied to businesses understood deeply, eventually selling if the thesis breaks.
Read more!
by Adrià Rivero - Inversión en Bolsa | 12/04/2025 09:00 AM | AXP
🏆 Warren Buffett's 1974 investment in American Express exemplifies the 'hunter' strategy: buying heavily into a quality company during market panic.
📈 Buffett's conviction led him to increase his AXP position when others were selling, a move that generated enormous long-term returns.
💎 The 'hunter' approach often involves high concentration in a few deeply understood companies with strong competitive advantages.
Read more!
by Adrià Rivero - Inversión en Bolsa | 10/04/2025 09:30 AM | GOOGL
📊 Market multiples, like the Price-to-Earnings (P/E) ratio, reflect current market sentiment and significantly impact short-term stock prices.
📉 Alphabet (Google) serves as a key example, with its P/E ratio contracting from nearly 35 times in 2022 to a projected 19 times in 2025 due to increased market negativity.
💡 Understanding shifts in multiples is crucial, as buying at a low multiple (like Google's current 19x) could lead to gains if market sentiment improves and the multiple expands, even without immediate changes in company fundamentals.
Read more!
by Adrià Rivero - Inversión en Bolsa | 07/04/2025 10:30 AM | JDG
🇬🇧 Judges Scientific, a UK firm acquiring scientific equipment makers, exports over 85% of its products, with the US being a key market, potentially exposing it to tariffs.
🔬 Despite tariff risks, its specialized products (spectrometers, microscopes) have high switching costs for clients like universities, offering resilience.
📈 The company shows historical resilience with minimal organic decline and could leverage market downturns to acquire smaller competitors at lower valuations.
Read more!
by Adrià Rivero - Inversión en Bolsa | 07/04/2025 10:30 AM | DHR
🏥 Danaher, a major health sector player, focuses on essential diagnostics, biotech, and life sciences technology and consumables, benefiting from the sector's defensive nature.
🛡️ With diversified global production, including significant US operations, Danaher has minimized direct import tariff risks for its critical, hard-to-substitute products.
💰 Known for strategic acquisitions via its Danaher Business System, the company could capitalize on lower valuations during a crisis to buy competitors at attractive prices.
Read more!